Ascentage is taking a strategic approach to chemistry, manufacturing, and controls (CMC) development for both clinical trials and the commercial market. First, contract development and manufacturing organizations (CDMOs) provide material supply; second, Ascentage is establishing internal capabilities and infrastructure, including its own manufacturing facility.
The Ascentage Pharma manufacturing facility in Suzhou, China is a key element of its organization as a fully integrated pharmaceutical company. The facility will enable the company to secure robust control of material supply, efficiently implement process updates, and fully realize long-term value from managing cost of goods.